We use cookies on our website to provide you with a better service.
More info
Accept all
More options
Strictly necessary cookies
Language cookie
Marketing cookies
Facebook Pixel
Performance cookies
Google Analytics
YouTube
Vimeo
More info
Accept all
Ok
screenreader.back to home
screenreader.open offcanvas menu
Portfolio
Team
News
Contact
back to Capricorn Partners
Capricorn Health
News
rss feed
News
Stay up to date
year
by year
2023
2022
2021
2020
2019
2018
2017
reset
2023
Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554
2 March 2023
2022
Filip Pintelon to represent Capricorn on the board of iSTAR Medical
30 November 2022
Capricorn Health-tech Fund supports its portfolio company iSTAR Medical entering into a Strategic Alliance with AbbVie for the Treatment of Glaucoma
20 July 2022
Capricorn Partners prepares its future further with a restyled logo and a new website
27 January 2022
2021
iSTAR Medical receives US FDA approval to start pivotal trial for MINIject in glaucoma patients
15 July 2021
Nexstim extends agreement with Canadian distributor and receives order for three NBT® systems
25 May 2021
Nexstim granted authorization for commercial distribution of NBS system in Australia
18 May 2021
Impressive new study results suggest potential new therapeutic use for Nexstim SmartFocus® nTMS in postsurgical rehabilitation of Paresis
17 May 2021
Confo Therapeutics awarded € 1 million VLAIO grant for pre-clinical development of CFTX-1554, an AT2R modulator for the treatment of neuropathic pain
30 March 2021
Nexstim gives an update on its promising treatment results of Major Depressive Disorder
12 March 2021
Mainstay Medical announces commercial launch of ReActiv8® in Australia
8 March 2021
Hologic acquires European Molecular diagnostic company Diagenode for approximately $159 million
1 March 2021
1
2
3
4
...
5